Liu X - Search Results

1

A comparison of the anti-tumor effects of a chimeric versus murine anti-CD19 immunotoxins on human B cell lymphoma and Pre-B acute lymphoblastic leukemia cell lines.

Tsai LK, Pop LM, Liu X, Vitetta ES. Tsai LK, et al. Among authors: liu x. Toxins (Basel). 2011 Apr;3(4):409-19. doi: 10.3390/toxins3040409. Epub 2011 Apr 6. Toxins (Basel). 2011. PMID: 22069716 Free PMC article.

2

Generation and characterization of a novel tetravalent anti-CD22 antibody with improved antitumor activity and pharmacokinetics.

Liu XY, Pop LM, Roopenian DC, Ghetie V, Vitetta ES, Smallshaw JE. Liu XY, et al. Int Immunopharmacol. 2006 May;6(5):791-9. doi: 10.1016/j.intimp.2005.11.022. Epub 2005 Dec 22. Int Immunopharmacol. 2006. PMID: 16546710

3

Chimeric, divalent and tetravalent anti-CD19 monoclonal antibodies with potent in vitro and in vivo antitumor activity against human B-cell lymphoma and pre-B acute lymphoblastic leukemia cell lines.

Liu XY, Pop LM, Tsai L, Pop IV, Vitetta ES. Liu XY, et al. Int J Cancer. 2011 Jul 15;129(2):497-506. doi: 10.1002/ijc.25695. Epub 2010 Nov 16. Int J Cancer. 2011. PMID: 20878959 Free article.

4

Immunotoxins constructed with chimeric, short-lived anti-CD22 monoclonal antibodies induce less vascular leak without loss of cytotoxicity.

Liu XY, Pop LM, Schindler J, Vitetta ES. Liu XY, et al. MAbs. 2012 Jan-Feb;4(1):57-68. doi: 10.4161/mabs.4.1.18348. MAbs. 2012. PMID: 22327430 Free PMC article.

5

The evaluation of recombinant, chimeric, tetravalent antihuman CD22 antibodies.

Meng R, Smallshaw JE, Pop LM, Yen M, Liu X, Le L, Ghetie MA, Vitetta ES, Ghetie V. Meng R, et al. Among authors: liu x. Clin Cancer Res. 2004 Feb 15;10(4):1274-81. doi: 10.1158/1078-0432.ccr-1154-03. Clin Cancer Res. 2004. PMID: 14977825

6

The generation of immunotoxins using chimeric anti-CD22 antibodies containing mutations which alter their serum half-life.

Pop LM, Liu X, Ghetie V, Vitetta ES. Pop LM, et al. Among authors: liu x. Int Immunopharmacol. 2005 Jul;5(7-8):1279-90. doi: 10.1016/j.intimp.2005.03.013. Epub 2005 Apr 26. Int Immunopharmacol. 2005. PMID: 15914332

7

Engineering therapeutic monoclonal antibodies.

Liu XY, Pop LM, Vitetta ES. Liu XY, et al. Immunol Rev. 2008 Apr;222:9-27. doi: 10.1111/j.1600-065X.2008.00601.x. Immunol Rev. 2008. PMID: 18363992 Review.

8

A reevaluation of CD22 expression in human lung cancer.

Pop LM, Barman S, Shao C, Poe JC, Venturi GM, Shelton JM, Pop IV, Gerber DE, Girard L, Liu XY, Behrens C, Rodriguez-Canales J, Liu H, Wistuba II, Richardson JA, Minna JD, Tedder TF, Vitetta ES. Pop LM, et al. Cancer Res. 2014 Jan 1;74(1):263-71. doi: 10.1158/0008-5472.CAN-13-1436. Cancer Res. 2014. PMID: 24395821 Free PMC article.

9

Efficient Carrier Multiplication in Self-Powered Near-Ultraviolet γ-InSe/Graphene Heterostructure Photodetector with External Quantum Efficiency Exceeding 161.

Li Y, Pan J, Yan C, Li J, Xin W, Zhang Y, Liu W, Liu X, Xu H, Liu Y. Li Y, et al. Among authors: liu x. Nano Lett. 2024 May 16. doi: 10.1021/acs.nanolett.4c01238. Online ahead of print. Nano Lett. 2024. PMID: 38753313

10

Research on high sensitivity piezoresistive sensor based on structural design.

Li W, Liu X, Wang Y, Peng L, Jin X, Jiang Z, Guo Z, Chen J, Wang W. Li W, et al. Among authors: liu x. Discov Nano. 2024 May 16;19(1):88. doi: 10.1186/s11671-024-03971-4. Discov Nano. 2024. PMID: 38753219 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

125,841 results

Search Page